Literature DB >> 25071081

Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model.

Satoko Hayakawa1, Koji Ohashi2, Rei Shibata1, Yoshiyuki Kataoka1, Megumi Miyabe1, Takashi Enomoto1, Yusuke Joki1, Yuuki Shimizu1, Takahiro Kambara1, Yusuke Uemura1, Daisuke Yuasa1, Hayato Ogawa1, Kazuhiro Matsuo1, Mizuho Hiramatsu-Ito1, Maurice J B van den Hoff3, Kenneth Walsh4, Toyoaki Murohara1, Noriyuki Ouchi2.   

Abstract

Heart disease contributes to the progression of CKD. Heart tissue produces a number of secreted proteins, also known as cardiokines, which participate in intercellular and intertissue communication. We recently reported that follistatin-like 1 (Fstl1) functions as a cardiokine with cardioprotective properties. Here, we investigated the role of cardiac Fstl1 in renal injury after subtotal nephrectomy. Cardiac-specific Fstl1-deficient (cFstl1-KO) mice and wild-type mice were subjected to subtotal (5/6) nephrectomy. cFstl1-KO mice showed exacerbation of urinary albumin excretion, glomerular hypertrophy, and tubulointerstitial fibrosis after subtotal renal ablation compared with wild-type mice. cFstl1-KO mice also exhibited increased mRNA levels of proinflammatory cytokines, including TNF-α and IL-6, NADPH oxidase components, and fibrotic mediators, in the remnant kidney. Conversely, systemic administration of adenoviral vectors expressing Fstl1 (Ad-Fstl1) to wild-type mice with subtotal nephrectomy led to amelioration of albuminuria, glomerular hypertrophy, and tubulointerstitial fibrosis, accompanied by reduced expression of proinflammatory mediators, NADPH oxidase components, and fibrotic markers in the remnant kidney. In cultured human mesangial cells, treatment with recombinant FSTL1 attenuated TNF-α-stimulated expression of proinflammatory cytokines. Treatment of mesangial cells with FSTL1 augmented the phosphorylation of AMP-activated protein kinase (AMPK), and inhibition of AMPK activation abrogated the anti-inflammatory effects of FSTL1. These data suggest that Fstl1 functions in cardiorenal communication and that the lack of Fstl1 production by myocytes promotes glomerular and tubulointerstitial damage in the kidney.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  albuminuria; cardiovascular; cell signaling; chronic inflammation; mesangial cells; renal injury

Mesh:

Substances:

Year:  2014        PMID: 25071081      PMCID: PMC4341480          DOI: 10.1681/ASN.2014020210

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  60 in total

Review 1.  The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart.

Authors:  Shirin Doroudgar; Christopher C Glembotski
Journal:  Trends Mol Med       Date:  2011-02-01       Impact factor: 11.951

2.  Structural characterization of TSC-36/Flik: analysis of two charge isoforms.

Authors:  Harald O Hambrock; Brigitte Kaufmann; Stefan Müller; Franz-Georg Hanisch; Kiyoshi Nose; Mats Paulsson; Patrik Maurer; Ursula Hartmann
Journal:  J Biol Chem       Date:  2003-12-30       Impact factor: 5.157

3.  Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.

Authors:  Ashish Upadhyay; Martin G Larson; Chao-Yu Guo; Ramachandran S Vasan; Izabella Lipinska; Christopher J O'Donnell; Sekar Kathiresan; James B Meigs; John F Keaney; Jian Rong; Emelia J Benjamin; Caroline S Fox
Journal:  Nephrol Dial Transplant       Date:  2010-08-03       Impact factor: 5.992

4.  Follistatin-like 1 regulates renal IL-1β expression in cisplatin nephrotoxicity.

Authors:  Derek C Adams; Michele J Karolak; Barry W Larman; Lucy Liaw; James D Nolin; Leif Oxburgh
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-22

Review 5.  The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-01       Impact factor: 2.894

6.  Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay.

Authors:  Christian Widera; Rüdiger Horn-Wichmann; Tibor Kempf; Kerstin Bethmann; Beate Fiedler; Sarita Sharma; Ralf Lichtinghagen; Holger Leitolf; Boris Ivandic; Hugo A Katus; Evangelos Giannitsis; Kai C Wollert
Journal:  Clin Chem       Date:  2009-07-02       Impact factor: 8.327

7.  Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis.

Authors:  Daisuke Kawabata; Masao Tanaka; Takao Fujii; Hisanori Umehara; Yoshimasa Fujita; Hajime Yoshifuji; Tsuneyo Mimori; Shoichi Ozaki
Journal:  Arthritis Rheum       Date:  2004-02

8.  Berberine suppresses proinflammatory responses through AMPK activation in macrophages.

Authors:  Hyun Woo Jeong; Kuan Chi Hsu; Joo-Won Lee; Mira Ham; Jin Young Huh; Hyun Jung Shin; Woo Sik Kim; Jae Bum Kim
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-02-10       Impact factor: 4.310

9.  Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway.

Authors:  Munehiro Kitada; Shinji Kume; Noriko Imaizumi; Daisuke Koya
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

Review 10.  AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan.

Authors:  Antero Salminen; Juha M T Hyttinen; Kai Kaarniranta
Journal:  J Mol Med (Berl)       Date:  2011-03-23       Impact factor: 4.599

View more
  30 in total

1.  C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism.

Authors:  Takahiro Kambara; Rei Shibata; Koji Ohashi; Kazuhiro Matsuo; Mizuho Hiramatsu-Ito; Takashi Enomoto; Daisuke Yuasa; Masanori Ito; Satoko Hayakawa; Hayato Ogawa; Tamar Aprahamian; Kenneth Walsh; Toyoaki Murohara; Noriyuki Ouchi
Journal:  Mol Cell Biol       Date:  2015-04-13       Impact factor: 4.272

2.  Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure.

Authors:  Mitsuru Seki; Jeffery C Powers; Sonomi Maruyama; Maria A Zuriaga; Chia-Ling Wu; Clara Kurishima; Lydia Kim; Jesse Johnson; Anthony Poidomani; Tao Wang; Eric Muñoz; Sudarsan Rajan; Joon Y Park; Kenneth Walsh; Fabio A Recchia
Journal:  Circ Heart Fail       Date:  2018-01       Impact factor: 8.790

3.  Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.

Authors:  Pei-Suen Tsou; Jonathan D Wren; M Asif Amin; Elena Schiopu; David A Fox; Dinesh Khanna; Amr H Sawalha
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

Review 4.  Cardiomyokines from the heart.

Authors:  Ayano Chiba; Haruko Watanabe-Takano; Takahiro Miyazaki; Naoki Mochizuki
Journal:  Cell Mol Life Sci       Date:  2017-12-13       Impact factor: 9.261

5.  FGF23 signaling impairs neutrophil recruitment and host defense during CKD.

Authors:  Jan Rossaint; Jessica Oehmichen; Hugo Van Aken; Stefan Reuter; Hermann J Pavenstädt; Melanie Meersch; Mark Unruh; Alexander Zarbock
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

6.  Transcriptome Analysis of Human Reninomas as an Approach to Understanding Juxtaglomerular Cell Biology.

Authors:  Alexandre G Martini; Lucie K Xa; Marie-Josée Lacombe; Alexis Blanchet-Cohen; Chantal Mercure; Benjamin Haibe-Kains; Edith C H Friesema; Anton H van den Meiracker; Kenneth W Gross; Michel Azizi; Pierre Corvol; Geneviève Nguyen; Timothy L Reudelhuber; A H Jan Danser
Journal:  Hypertension       Date:  2017-04-10       Impact factor: 10.190

Review 7.  Follistatin-like 1 and its paralogs in heart development and cardiovascular disease.

Authors:  Martin Horak; DeLisa Fairweather; Piia Kokkonen; David Bednar; Julie Bienertova-Vasku
Journal:  Heart Fail Rev       Date:  2022-07-22       Impact factor: 4.654

8.  The expression and post-transcriptional regulation of FSTL1 transcripts in placental trophoblasts.

Authors:  Jean-Francois Mouillet; Takuya Mishima; Andrea Mollica do Amarante Paffaro; Tony W Parks; Judy A Ziegler; Tianjiao Chu; Yoel Sadovsky
Journal:  Placenta       Date:  2015-09-10       Impact factor: 3.481

Review 9.  Hypoxia: The Force that Drives Chronic Kidney Disease.

Authors:  Qiangwei Fu; Sean P Colgan; Carl Simon Shelley
Journal:  Clin Med Res       Date:  2016-02-04

10.  Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune Diseases.

Authors:  Xiaohe Li; Yinshan Fang; Dingyuan Jiang; Yingying Dong; Yingying Liu; Si Zhang; Jiasen Guo; Chao Qi; Chenjing Zhao; Fangxin Jiang; Yueyue Jin; Jing Geng; Cheng Yang; Hongkai Zhang; Bin Wei; Jiurong Liang; Chen Wang; Huaping Dai; Honggang Zhou; Dianhua Jiang; Wen Ning
Journal:  Mol Ther       Date:  2020-09-23       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.